This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Medicis Pharmaceutical Corporation, Merck Patent Gmbh. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Jie Li: Innovator in Pharmaceutical Chemistry
Introduction
Jie Li is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications.
Latest Patents
Jie Li holds a patent for "3′,5′-dimethoxybenzoyl-3'-amino-3′-deoxy adenosine-5′-triphosphates and pharmaceutical uses thereof." This patent includes compounds that exhibit P2X3 receptor or P2X2/3 receptor antagonist activity. These compounds are useful for treating diseases and disorders characterized by the activation of these receptors.
Career Highlights
Throughout his career, Jie Li has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Danmir Therapeutics, LLC. His work has focused on innovative solutions to complex medical challenges.
Collaborations
Jie Li has collaborated with esteemed colleagues such as Amir Pelleg and Anu Mahadevan. These partnerships have contributed to the advancement of his research and the development of new therapeutic compounds.
Conclusion
Jie Li's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the field. His work continues to impact the development of treatments for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile